2 Department of Human Anatomy and Cell Sciences, Faculty of Medicine, University of Manitoba, Winnipeg MB R3E 3J7, Canada
1 Physiology, Faculty of Medicine, University of Manitoba, Winnipeg MB R3E 3J7, Canada
3 Institute of Cardiovascular Sciences, SBGH Research Centre 3008, 351 Tache Avenue, Winnipeg MB R2H 2A6, Canada
4 Department of Medicine, University of Louisville, Louisville, KY 40292, USA
Author for correspondence (e-mail: ekardami{at}sbrc.ca)
Accepted 17 September 2003
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Connexin43, Phosphorylation mutants, DNA synthesis, Cell-cell contact, Cardiomyocytes
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cx43 is the main constituent of the GJ in working cardiomyocytes, and has been the subject of numerous investigations in the context of adult cardiac function and maintenance of proper rhythm (Dhein, 1998; Kanno and Saffitz, 2001
). It has never been examined in the context of cardiomyocyte hyperplastic growth. Our previous studies provided evidence for a link between mitogenic stimulation of neonatal cardiomyocytes and effects on Cx43. Fibroblast growth factor 2, FGF2, stimulates cardiomyocyte proliferation (Kardami, 1990
; Pasumarthi et al., 1996
) as well as protein kinase C (PKC;
subtype)-dependent additional serine phosphorylation of Cx43 (Doble et al., 1996
; Doble et al., 2000b
). In contrast, transforming growth factor ß, a factor that cancels out the mitogenic effect of FGF2 on cardiomyocytes (Kardami, 1990
), prevented the FGF2-induced Cx43 phosphorylation (Kardami, 1998). These data suggested that the phosphorylation status and pattern of Cx43 and/or coupling between cells, may be important in cardiomyocyte cell cycle regulation.
Cx43 exists in a phosphorylated state in both neonatal and adult cardiomyocytes (Beardslee et al., 2000; Laird et al., 1991
). Phosphorylation occurs at several different sites on the molecule and regulates trafficking, assembly, turnover and coupling (Lampe and Lau, 2000
). Our previous studies suggested that mitotic stimulation may result in a PKC-mediated phosphorylation of Cx43 on S262 (Doble et al., 1996
; Doble et al., 2000a
). Whether Cx43 phosphorylation at any one site, including S262, can affect its ability to inhibit DNA synthesis is not known. In fact, the mechanism of cell cycle (DNA synthesis) inhibition by Cx43, and the role of intercellular communication is not well understood. It has been proposed that GJ-mediated intercellular communication is an integral part of the mechanism of inhibition, by allowing passage of growth affecting signals between cells (Goldberg et al., 2000
; Loewenstein and Rose, 1992
). There is, however, increasing evidence of channel-independent growth inhibition by Cx43 (Dang et al., 2003
; Krutovskikh et al., 2000
; Moorby and Patel, 2001
; Moorby, 2000
).
We present evidence that Cx43 can inhibit DNA synthesis also in primary cardiomyocytes. Furthermore, we have addressed several elements of the mechanism of Cx43-inhibition. These include the role of cell-cell contact and/or coupling, and the role of phosphorylation at a specific serine residue, S262.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
For most experiments, myocytes were plated at 4x105 cells/35 mm collagen-coated dish, in 10% foetal bovine serum (FBS) in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10 ng/ml FGF2 (conditions of maximal mitogenic stimulation). Under these conditions cells were about 60% confluent 1 day after plating. In some experiments, myocytes were seeded at low densities, at 5x104 cells/35 mm well. For scrape-loading, cardiomyocytes were plated at high density (9x106/35 mm dish) and maintained as described previously (Doble et al., 1996; Doble et al., 2000b
).
Antibodies
Polyclonal anti-Cx43 antibodies, raised against residues 367-382, have been described previously (Doble et al., 2000b). Monoclonal anti-Cx43 antibodies (against residues 252-270) were purchased from Transduction Laboratories; their specificity for Cx43 was ascertained in previous studies (Doble et al., 1996
). Rabbit polyclonal antibodies for phosphorylated (serine 262; P-262) Cx43 and anti-N-cadherin antibodies were purchased from Santa Cruz Biotechnology. Monoclonal anti-bromodeoxyuridine (BrdU), anti-rabbit immunoglobulin (biotinylated species-specific whole antibody), streptavidin-fluorescein and mouse immunoglobulin (whole antibody linked to Texas Red) were from Amersham Polysciences. Rabbit polyclonal anti-(rodent) Ki-67 antibodies were from Novocastra (UK).
Connexin43 mutagenesis
The plasmid pBSM13-Cx43 (rat origin; kindly provided by Dr E. Beyer) (Beyer et al., 1987) was used as the template for PCR-mediated site-directed mutagenesis. The primers: 5'-CGATCCTTACCACGCCACCACTGGCCCACTGAGCCCATCAAAAGACTGCGGAgCTCCAAAATAC-3' (S262A sense primer) and 5'-CGATCCTTACCACGCCACCACTGGCCCACTGAGCCCATCAAAAGACTGCGGAgaTCCAAAATAC-3' (S262D sense primer) were used in combination with the primer 5'-CCATGCGATTTTGCTCTGCGCTGTAG-3' (antisense primer) to generate two 229 bp fragments, which were mutated in position 262 from either serine (S) to alanine (A) or from S to aspartate (D) in the connexin43 cDNA, respectively. The primers: 5'-GTTTTGCTCGCTAGCTTGCTTGTTGTAATTGC GGCACGcGGAATTGTTTCTG-3' (S297A antisense primer) and 5'-CAGGCCGAGGCCTGCTGCTGGCGCGGCTGCTGGCTCTGCTGGcAGGTCGTTGG-3' (S364A antisense primer) were used in combination with the primer 5'-CGTTAAGGATCGCGTGAAGGGAAGAAGC-3' (sense primer) to generate either (i) a 222 bp fragment with S297 converted to A; or (ii) a 427 bp fragment with S364 converted to A; in the Cx43 cDNA, respectively. The PCR reactions were carried out as previously described (Jin et al., 1994
). The PCR products were digested with XcmI/NheI for the S262A, S262D and S297A mutants or with XcmI/StuI for the S364A mutant. The digested PCR products were then subcloned into the XcmI/NheI or XcmI/StuI site of pBSM13 Cx43 plasmid to generate the pBSM13-Cx43/S262A, pBSM13-Cx43/S262D, pBSM13-Cx43/S297A and pBSM13-Cx43/S364A mutant constructs. Sequences were checked by the dideoxy method using the fmfol DNA Cycle Sequencing System Kit (Promega Corp., Madison, WI). The full length wild-type (wt) and mutated Cx43 fragments (1391 bp) were released by EcoRV/XbaI digestion and ligated into the EcoRV/XbaI site of the mammalian expression vector pcDNA3.1(+) (Invitrogen, Carlsbad, CA) for use in infection experiments.
Western blotting
Total cell protein was obtained using a lysis buffer composed of 1% SDS in 50 mM Tris-HCl pH 8.0. Subcellular fractionation to cytosolic, Triton-soluble and Triton-insoluble fractions were done as described by others (Musil and Goodenough, 1991). Protein content was determined using the BCA assay (Pierce). Samples were prepared in Laemmli sample buffer (Laemmli, 1970
) and analyzed by SDS-PAGE (10% polyacrylamide gels) and western blotting as previously described (Doble et al., 2000b
).
Adenoviral vectors
We have used replication-deficient adenovirus as a vehicle for highly efficient gene delivery (over 90%) in cardiomyocytes (Doble et al., 2000b; Kirshenbaum, 1997
; Kirshenbaum et al., 1993
). Recombinant adenoviral vectors carrying the 262A-, 262D- or wt-Cx43 genes under the control of the CMV promoter were constructed as described previously (Ping et al., 1999
). Recombinant viruses were prepared as high-titer stocks through propagation in HEK 293 cells. Infection with Ad.CMV.ß-gal was used in all experiments to control for non-connexin-related effects of viral infection.
Transient gene transfer
Adenovirally mediated gene transfer was achieved by adding the required viral construct (10 m.o.i.) to the myocyte cultures, one day after plating. For all experiments aimed at examining effects on DNA synthesis, myocytes were maintained in the presence of 10% FBS supplemented with 10 ng/ml FGF2 for up to 3 days. Non-myocyte contamination did not exceed 5% during this time. For `scrape-loading', myocytes were infected with adenoviral vectors one day before the experiment.
Immunofluorescent labelling
Immunofluorescent labelling and nuclear staining with Hoechst 33342 was carried out as previously described (Doble et al., 1996; Doble et al., 2000b
). Briefly, cells, grown on collagen-coated glass coverslips, were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) and permeabilized with 0.1% Triton X-100 in PBS. Our own rabbit polyclonal Cx43 antibody was used at a dilution of 1:5,000; the anti-BrdU monoclonal antibody was used undiluted. All other antibodies were used as per manufacturer's instructions. In all experiments, non-specific fluorescent staining was examined by incubating cells in the presence of equivalent concentrations of non-immune rabbit or mouse sera.
Determination of BrdU labelling index
Myocytes were allowed to express transiently introduced genes for up to 48 hours. They were incubated with 15 µg/ml BrdU (Sigma) for 6 hours. Subsequently, cells were fixed and processed for multiple fluorescence labelling. In most experiments, the identity of myocytes was confirmed by the characteristic striated staining of alpha-actinin or striated myosin in the cytosol, as we have shown previously (Pasumarthi et al., 1996). Staining of N-cadherin at intercellular contacts also served to identify myocytes. A minimum of eight random fields in each of at least three coverslips per group were assessed. Labelling index (LI) was determined by dividing the number of BrdU-positive myocyte nuclei by the total number of myocyte nuclei (Hoechst positive), per field. Labelling index for Ki-67 was obtained in a similar fashion.
Scrape loading
Confluent rat cardiomyocyte cultures were used and dye transfer assessed exactly as described previously (Doble et al., 1996; Doble et al., 2000b
). Cells were scrape-loaded with 6-carboxyfluorescein and fixed 2 minutes later. Spread of fluorescence dye was measured at several points at the centre of the scrape line. Under these conditions, fluorescent dextran (10,000 Da) does not spread past the scrape line (Doble et al., 1996
), indicating that the movement of carboxyfluorescein is achieved via gap junctions.
Statistics
Comparisons were made between cultures infected with vector (controls) and those infected with Cx43 (wt, S262A, or S262D) using the student-Newman-Keuls multiple comparisons post-hoc test, following analysis of variance (InStat, GraphPad Software, San Diego, CA).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Expression and localization of wt-, 262A- and 262D-Cx43 in rat cardiomyocytes
Expression of the introduced Cx43 genes (wt-, 262A-, 262D-Cx43) following adenoviral gene delivery was evaluated by western blotting and immunolocalization. All cells treated with vectors expressing Cx43 and its mutants, as well as control myocytes produced immunoreactive Cx43 bands migrating mostly at 44-47 kDa. The amount of Cx43 present in 1 µg lysate from cultures treated with vectors expressing Cx43 or its mutants was comparable to endogenous Cx43 present in a 10-fold amount of lysate from vector-infected cells (Fig. 2A).
|
Fig. 2B-D shows Cx43 localization in control and overexpressing cultures. Cx43 was visualized by indirect immunofluorescence, using two different antibodies to Cx43. The polyclonal antibody (`green') detects Cx43 mainly at cell-cell contact areas, while the monoclonal antibody (`red') raised against a different region of the molecule, detects Cx43 at sites of cell-cell contact as well as synthesis and trafficking around the nucleus. Since both antibodies are specific for Cx43, lack of perinuclear staining by the polyclonal antibody is likely the result of epitope masking. Epitope masking of anti-Cx43 antibodies has been reported in other studies (Doble et al., 1996; Ochalski et al., 1995
). Together the two antibodies provide a more comprehensive picture of Cx43 abundance compared to any one antibody used on its own. As expected, overall intensity of anti-Cx43 staining with both antibody preparations (resulting in yellow colour) was very strong at cell-cell contact areas in overexpressing cultures; intensity of anti-Cx43 staining was weak in vector-infected cultures (Fig. 2B). No differences in the pattern of subcellular Cx43 distribution between wt-, 262A- or 262D-Cx43 overexpressing cultures were evident. Identical results were obtained when wt and mutant connexins were transiently expressed in non cardiac cell lines expressing undetectable levels of endogenous Cx43, such as HEK293 cells (unpublished observations). We also compared the solubility properties of the overexpressed versus endogenous connexins. We have observed previously that unlike its properties in other cell types (Musil and Goodenough, 1991
) Cx43 from non-ischemic cardiac myocytes shows very little solubility in 0.5-1% Triton-X-100, and this was true for both unphosphorylated and phosphorylated Cx43 (unpublished observations) (Doble et al., 1996
). Cytosolic, Triton-X-100-soluble and Triton-X-100-insoluble fractions from control or overexpressing myocyte cultures were analyzed for Cx43 by western blotting. In all cases, Cx43 immunoreactivity was detectable only in the Triton-insoluble fraction, confirming that all overexpressed connexins retained similar aggregation properties as endogenous cardiac Cx43 (unpublished observations).
Effect of Cx43 and S262 on DNA synthesis in the presence or absence of cell-cell contact
To achieve cell-cell contact and at the same time avoid overcrowding, cardiomyocytes were plated at semi-confluent densities. Under these conditions virtually all myocytes were present in clusters, making contact with at least one more myocyte (Figs 3 and 4). Cells were maintained under maximal mitogen stimulation to facilitate detection and comparison of `treatments' that would inhibit stimulation. Gene delivery by non-replicating adenoviral vectors were used to overexpress wt and mutant Cx43 species, achieving over 90% efficiency of gene transfer (verified in each experiment by anti-Cx43 immunostaining). Incorporation of BrdU was used to detect DNA synthesis in nuclei (Fig. 3). In parallel experiments nuclear labelling for Ki-67 was also used as a marker of cell proliferation (Fig. 4). Ki-67 detects cells in G1, S, G2 and early mitosis, but not in G0 (Brown and Gatter, 2002). These approaches gave similar results (Figs 3 and 4). Fig. 5A shows quantitative results on the effect of wt and mutant Cx43 overexpression on myocyte BrdU LI (fraction of BrdU-positive myocyte nuclei): expression of wt-Cx43 decreased the BrdU LI significantly, by 60% (P<0.001 compared to vector-infected cells). Expression of 262A-Cx43 resulted in significantly more potent inhibition, by 84% (P<0.001 compared to vector-infected, and P<0.01 compared to the wt-Cx43 infected cells). Expression of 262D-Cx43 had no inhibitory effect at all (Fig. 5A) and was indistinguishable from vector-infected cells. The degree of Cx43 overexpression was similar between cultures treated with vectors expressing Cx43 or its mutants, and within each experimental series (Figs 2, 3, 4). The same pattern of response was obtained in three separate experiments, and when calcium-phosphate-mediated transient gene transfer was employed (Doble et al., 2000b
).
|
|
|
To examine whether Cx43 and its mutants had an effect on proliferation of non-interconnected cardiomyocytes (i.e. in the absence of GJ channels and cell-cell communication) we used sparsely seeded cultures. These cultures contained mostly isolated myocytes, although clusters of 2-4 myocytes were also occasionally present. The latter were excluded from our determinations. Results are summarized in Fig. 5B. Overexpression of wt, or either of the S262-Cx43 mutants caused a significant (P<0.01) drop in LI compared to vector-infected cultures. In this case however, there were no significant differences in LI between wt and either of the two mutated connexin-expressing cells. The same pattern of response was obtained in two separate experiments. Both BrdU and Ki-67 LI were obtained, giving qualitatively similar results.
Effect of S262 on dye transfer between cardiomyocytes
Cell-cell contact allows formation of GJ channels and cell-cell communication. The effect of S262 mutations on Cx43 inhibition of DNA synthesis may be mediated by changes in GJ permeability. A first step towards clarifying this would be to establish whether the S262 mutations alter GJ-mediated dye transfer between cells. Thus we used the scrape loading approach to compare the effects of overexpressing wt and mutant Cx43 on dye spread between cardiomyocytes. Results are summarized in Fig. 6. Dye spreading was not significantly different between vector, wt- and 262D-Cx43-infected cells. Dye spreading was significantly increased (P<0.05) in cultures overexpressing 262A-Cx43 compared to all other groups. Fig. 6 shows a representative image of fluorescent dye migration in myocyte cultures expressing 262A- or 262D-Cx43 (Fig. 6A and B, respectively). The same pattern of response was obtained in three different experiments.
|
Stimulation with the phorbol ester PMA (and the ensuing Cx43 phosphorylation on multiple sites) is well known to diminish dye coupling between cells (Kwak and Jongsma, 1996). To test whether S262 is solely responsible for mediating the effects of PMA, dye transfer was assessed after stimulating all myocyte cultures with this compound for 15 minutes. Under these conditions, dye spreading became minimal and similar in all groups. Fig. 6C summarizes the effect of PMA on dye spreading in cultures overexpressing 262A- or 262D-Cx43.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A role for Cx43 in cardiomyocyte DNA synthesis
The ability of cardiac myocytes to synthesise DNA and divide decreases after birth. This correlates with presence of multiple, well-established cell-cell contacts and Cx43-composed GJ at the intercalated discs between working cardiomyocytes. Cx43 is capable of inhibiting proliferation of neoplastic cells (Yamasaki et al., 1999), preventing the transition to the S-phase (Zhang et al., 2001
). We show for the first time that primary neonatal cardiomyocytes are susceptible to Cx43-mediated inhibition of DNA synthesis, since overexpression of wt Cx43 reduced the fraction of myocytes incorporating BrdU or staining positive for Ki-67. Assuming that our data from cultured myocytes provide a good simulation of the situation in vivo, a channel protein, Cx43, in addition to ensuring electrical and metabolic coupling, may also be regarded as a potential suppressor of cardiomyocyte proliferation, at least in the embryonic and early post-natal stages.
Mechanism of growth inhibition by Cx43
An ongoing debate regarding the mechanism of growth inhibition by Cx43 is whether it requires the presence of active GJ channels and transmission of GJ-permeable signals. Several groups have suggested that inhibitory factors diffusing through the GJ channels mediate growth inhibition (Esinduy et al., 1995; Mehta et al., 1986
; Mehta et al., 1991
; Zhang et al., 2001
). Others have reported that Cx43 can inhibit growth in a manner independent of channel permeability and/or subcellular localization (Krutovskikh et al., 2000
; Moorby and Patel, 2001
). In fact, the non-channel forming, C-terminal `tail' of Cx43 retains growth inhibitory activity (Dang et al., 2003
; Moorby and Patel, 2001
). In our system, inhibition was detected irrespective of cell-cell contact (Fig. 5), supporting the notion that Cx43-mediated inhibition of cardiomyocyte DNA synthesis does not require formation of GJ channels. A possible mechanism may involve interactions of Cx43 with other proteins and/or protein complexes that can regulate the cell cycle. Proteins such as ZO-1,
PKC, Src or ß-catenin, all of which have been implicated in regulation of cell proliferation, are known to interact with Cx43 (Ai et al., 2000
; Doble et al., 2000b
; Giepmans et al., 2001
; Lin et al., 2001
). It is also theoretically possible that Cx43 may affect gene expression directly, acting as a transcription factor, or indirectly by interacting with transcription affecting protein(s) or complexes. The C-terminal tail of Cx43 can localize to the nucleus (Dang et al., 2003
) where it may have effects on gene expression.
The role of S262 phosphorylation and cell-cell contact on Cx43 inhibition of DNA synthesis
While Cx43 and FGF2 have opposing effects on cardiomyocyte DNA synthesis they are `linked' by a regulatable event, Cx43 phosphorylation in response to FGF2 stimulation. We therefore asked the question whether the mitogen-induced and PKC-mediated phosphorylation of Cx43 (Doble et al., 1996; Doble et al., 2000b
) were actually required for stimulation of DNA synthesis. To address this it was important to identify the particular serine(s) becoming phosphorylated on Cx43 in response to stimulation, and then create a model to examine functional consequences (inhibition of DNA synthesis, dye coupling) of selectively interfering with the phosphorylation status of that serine.
Our previous work pointed to S262 as a site that becomes phosphorylated in response to growth factor stimulation, in a PKC-dependent manner (Doble et al., 1996; Doble et al., 2000a
). The recent availability of anti-P-S262-Cx43 antibodies enabled us to demonstrate directly that indeed FGF2, and PMA, stimulate phosphorylation of Cx43 on S262. The antibodies detected Cx43 only after PKC stimulation and the apparent size of immunoreactive bands (45-49 kDa) further corroborated their phosphorylated status. Since S262 phosphorylation was only detected after stimulation of an already phosphorylated protein, and was associated with only the slower migrating bands, it is possible that phosphorylation at other sites is necessary before S262 can become phosphorylated. PMA resulted in more extensively phosphorylated Cx43 (i.e. presenting slower electrophoretic mobility) compared to FGF2, reflecting, presumably, phosphorylation at sites in addition to S262. Other PKC sites that may become phosphorylated in cardiomyocytes include S364 (Britz-Cunningham et al., 1995
), S372 and S368 (Saez et al., 1997
).
We then created single mutations on Cx43 designed to simulate the charge effects incurred by lack of (S-to-A) or constitutive (S-to-D) phosphorylation on serine 262, and examined whether these mutants, overexpressed in proliferative myocyte cultures by adenoviral gene delivery, would affect cardiomyocyte DNA synthesis. Overexpression of wt-Cx43 provided an additional `baseline' for comparison, in addition to non-overexpressing, vector-only-treated myocytes. Interestingly, we found that our results were dependent on whether cardiomyocytes were `isolated' or in contact with each other: in the presence of cell-cell contact, prevention of phosphorylation (S262A) resulted in maximal inhibition of DNA synthesis (by 84%, compared to vector-infected cultures). Simulated constitutive phosphorylation at the same site (S262D) completely cancelled Cx43 inhibition. In the absence of cell contact, however, S262 did not affect Cx43-mediated inhibition of DNA synthesis. Overexpression per se was not responsible for the effects on DNA synthesis, since the same level of overexpression resulted in pronounced (S262A), intermediate (wt) and no (S262D) inhibition in contact-forming myocytes. A single amino acid therefore can cancel or potentiate growth inhibition by Cx43 depending on whether it is phosphorylated or not. We speculate that Cx43 phosphorylation on S262 may be a component of the mechanism by which mitogens promote DNA synthesis and proliferation in myocytes remaining in contact with each other, during embryonic and early post-natal stages. The effects of S262 mutations were not specific for cardiomyocytes. Transient expression of the wt and S262 mutants in cells with undetectable levels of endogenous Cx43 (HEK293) elicited identical effects on DNA synthesis (unpublished observations).
Cell-cell contact would allow GJ-mediated intercellular communication. Since S262 can affect gap junction dye permeability as presented here, one must consider the possibility that the mechanism by which S262 phosphorylation (or lack thereof) affects DNA synthesis includes as yet unknown GJ permeable signals. The absence of S262 regulation in the non-coupled myocytes offers support to this notion. This, however, remains to be demonstrated. Another possibility is that cell-cell contact promotes phenotypic changes that affect the mechanism by which Cx43 exerts inhibition. For example the protein(s) interacting with Cx43 may be different depending on cell contact, and S262 may only interfere with these interactions in contact-forming cells.
S262 affects GJ permeability to dyes
Overexpression of S262A-Cx43 enhanced dye transfer between myocytes, indicating that S262 affects GJ permeability. Increased coupling by S262A was not a result of overexpression per se since it was not observed in cultures overexpressing wt- or S262D-Cx43. The question arises as to whether our findings reflect permeability properties of channels composed mainly of the introduced S262A-Cx43 or an indirect effect of the introduced connexins on channels composed of endogenous Cx43. The first possibility appears more likely since all connexin constructs introduced by gene transfer retain intact connexin-forming domains, were expressed at an over 10-fold excess over the endogenous protein, and displayed a localization pattern identical to endogenous Cx43. In either case, however, the S262A mutation resulted in more permeable GJ between cardiomyocytes.
The S262 site was not sufficient to account for the effects of PMA on dye coupling. If it was, the S262A- or S262D-expressing cultures would not display decreased coupling in response to PMA (Fig. 6). Since PMA stimulates phosphorylation of additional sites on Cx43 (Lampe and Lau, 2000; Saez et al., 1997
) (Fig. 1), these sites probably contribute to decreased channel permeability and mask the effects of the S262A mutation. One such site is serine 368 that accounts to a large degree for the PMA-induced effects on Cx43-mediated dye transfer in mouse fibroblasts (Lampe and Lau, 2000
).
In conclusion
We have shown that overexpression of Cx43 inhibits DNA synthesis of neonatal cardiomyocytes in primary culture irrespectively of cell-cell contact and thus GJ-mediated communication. For the first time we provide evidence that regulation of inhibition by Cx43 differs depending on cell-cell contact and possibly GJ-mediated communication. In the absence of cell-cell contact inhibition is independent of S262, while in the presence of cell-cell contact it becomes dependent on the phosphorylation status of S262. What follows is the novel concept that cardiomyocytes need actually to be in contact with each other for mitogens to overcome Cx43-mediated inhibition of DNA synthesis by stimulating S262 phosphorylation. It remains to be determined whether our findings are applicable to cardiomyocytes in vivo.
![]() |
Acknowledgments |
---|
![]() |
Footnotes |
---|
Present address: Department of Medicine, UCLA, Los Angeles, CA 90095-1760, USA
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Ai, Z., Fischer, A., Spray, D. C., Brown, A. M. and Fishman, G. I. (2000). Wnt-1 regulation of connexin43 in cardiac myocytes. J. Clin. Invest. 105, 161-171.
Beardslee, M. A., Lerner, D. L., Tadros, P. N., Laing, J. G., Beyer, E. C., Yamada, K. A., Kleber, A. G., Schuessler, R. B. and Saffitz, J. E. (2000). Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ. Res. 87, 656-662.
Beyer, E. C., Paul, D. L. and Goodenough, D. A. (1987). Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J. Cell Biol. 105, 2621-2629.[Abstract]
Britz-Cunningham, S. H., Shah, M. M., Zuppan, C. W. and Fletcher, W. H. (1995). Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. New Engl. J. Med. 332, 1323-1329.
Brown, D. C. and Gatter, K. C. (2002). Ki67 protein: the immaculate deception? Histopathology 40, 2-11.[CrossRef][Medline]
Dang, X., Doble, B. W. and Kardami, E. (2003). The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol. Cell. Biochem. 242, 35-38.[CrossRef][Medline]
Dhein, S. (1998). Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol. Sci. 19, 229-241.[CrossRef][Medline]
Doble, B. W., Chen, Y., Bosc, D. G., Litchfield, D. W. and Kardami, E. (1996). Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ. Res. 79, 647-658.
Doble, B. W., Dang, X., Jin, Y., Cattini, P. A. and Kardami, E. (2000a). Phosphorylation of a specific serine on connexin-43 affects cardiomyocyte proliferation. Mol. Biol. Cell 11 Supplement, 224A.
Doble, B. W., Ping, P. and Kardami, E. (2000b). The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ. Res. 86, 293-301.
Doble, B. W., Ping, P., Fandrich, R. R., Cattini, P. A. and Kardami, E. (2001). Protein kinase C-epsilon mediates phorbol ester-induced phosphorylation of connexin-43. Cell Commun. Adhes. 8, 253-256.[Medline]
Esinduy, C. B., Chang, C. C., Trosko, J. E. and Ruch, R. J. (1995). In vitro growth inhibition of neoplastically transformed cells by non-transformed cells: requirement for gap junctional intercellular communication. Carcinogenesis 16, 915-921.[Abstract]
Giepmans, B. N., Verlaan, I. and Moolenaar, W. H. (2001). Connexin-43 interactions with ZO-1 and alpha- and beta-tubulin. Cell Commun. Adhes. 8, 219-223.[Medline]
Goldberg, G. S., Bechberger, J. F., Tajima, Y., Merritt, M., Omori, Y., Gawinowicz, M. A., Narayanan, R., Tan, Y., Sanai, Y., Yamasaki, H. et al. (2000). Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res. 60, 6018-6026.
Goodenough, D. A., Goliger, J. A. and Paul, D. L. (1996). Connexins, connexons, and intercellular communication. Annu. Rev. Biochem. 65, 475-502.[CrossRef][Medline]
Jin, Y., Pasumarthi, K. B., Bock, M. E., Lytras, A., Kardami, E. and Cattini, P. A. (1994). Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. J. Mol. Cell. Cardiol. 26, 1449-1459.[CrossRef][Medline]
Kanno, S. and Saffitz, J. E. (2001). The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc. Pathol. 10, 169-177.[CrossRef][Medline]
Kardami, E. (1990). Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol. Cell. Biochem. 92, 129-135.[Medline]
Kardami, E. and Doble, B. W. (1998). Cardiomyocyte gap junctions: a target for growth factor signalling. Trends Cardiov. Med. 8, 180-187.[CrossRef]
King, T. J., Fukushima, L. H., Donlon, T. A., Hieber, A. D., Shimabukuro, K. A. and Bertram, J. S. (2000). Correlation between growth control, neoplastic potential and endogenous connexin43 expression in HeLa cell lines: implications for tumor progression. Carcinogenesis 21, 311-315.
Kirshenbaum, L. A. (1997). Adenovirus mediated-gene transfer into cardiomyocytes. Mol. Cell. Biochem. 172, 13-21.[CrossRef][Medline]
Kirshenbaum, L. A., MacLellan, W. R., Mazur, W., French, B. A. and Schneider, M. D. (1993). Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J. Clin. Invest. 92, 381-387.[Medline]
Krutovskikh, V. A., Troyanovsky, S. M., Piccoli, C., Tsuda, H., Asamoto, M. and Yamasaki, H. (2000). Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 19, 505-513.[CrossRef][Medline]
Kwak, B. R. and Jongsma, H. J. (1996). Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol. Cell. Biochem. 157, 93-99.[Medline]
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.[Medline]
Laird, D. W., Puranam, K. L. and Revel, J. P. (1991). Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem. J. 273, 67-72.[Medline]
Lampe, P. D. and Lau, A. F. (2000). Regulation of gap junctions by phosphorylation of connexins. Arch. Biochem. Biophys. 384, 205-215.[CrossRef][Medline]
Lin, R., Warn-Cramer, B. J., Kurata, W. E. and Lau, A. F. (2001). v-Src-mediated phosphorylation of connexin43 on tyrosine disrupts gap junctional communication in mammalian cells. Cell Commun. Adhes. 8, 265-269.[Medline]
Loewenstein, W. R. and Rose, B. (1992). The cell-cell channel in the control of growth. Semin. Cell Biol. 3, 59-79.[Medline]
Mehta, P. P., Bertram, J. S. and Loewenstein, W. R. (1986). Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44, 187-196.[Medline]
Mehta, P. P., Hotz-Wagenblatt, A., Rose, B., Shalloway, D. and Loewenstein, W. R. (1991). Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J. Membr. Biol. 124, 207-225.[Medline]
Mesnil, M., Krutovskikh, V., Piccoli, C., Elfgang, C., Traub, O., Willecke, K. and Yamasaki, H. (1995). Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res. 55, 629-639.[Medline]
Moorby, C. and Patel, M. (2001). Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Exp. Cell Res. 271, 238-248.[CrossRef][Medline]
Moorby, C. D. (2000). A connexin 43 mutant lacking the carboxyl cytoplasmic domain inhibits both growth and motility of mouse 3T3 fibroblasts. Mol. Carcinog. 28, 23-30.[CrossRef][Medline]
Musil, L. S. and Goodenough, D. A. (1991). Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J. Cell Biol. 115, 1357-1374.[Abstract]
Ochalski, P. A., Sawchuk, M. A., Hertzberg, E. L. and Nagy, J. I. (1995). Astrocytic gap junction removal, connexin43 redistribution, and epitope masking at excitatory amino acid lesion sites in rat brain. Glia 14, 279-294.[Medline]
Pasumarthi, K. B., Kardami, E. and Cattini, P. A. (1996). High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ. Res. 78, 126-136.
Ping, P., Zhang, J., Cao, X., Li, R. C., Kong, D., Tang, X. L., Qiu, Y., Manchikalapudi, S., Auchampach, J. A., Black, R. G. et al. (1999). PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am. J. Physiol. 276, H1468-1481.[Medline]
Saez, J. C., Nairn, A. C., Czernik, A. J., Fishman, G. I., Spray, D. C. and Hertzberg, E. L. (1997). Phosphorylation of connexin43 and the regulation of neonatal rat cardiac myocyte gap junctions. J. Mol. Cell. Cardiol. 29, 2131-2145.[CrossRef][Medline]
Yamasaki, H., Krutovskikh, V., Mesnil, M., Tanaka, T., Zaidan-Dagli, M. L. and Omori, Y. (1999). Role of connexin (gap junction) genes in cell growth control and carcinogenesis. C. R. Acad. Sci. Ser. III 322, 15115-15119.
Zhang, Y. W., Morita, I., Ikeda, M., Ma, K. W. and Murota, S. (2001). Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene 20, 4138-4149.[CrossRef][Medline]
Zhu, D., Caveney, S., Kidder, G. M. and Naus, C. C. (1991). Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci. USA 88, 1883-1887.[Abstract]